Diagnostic work-up of acute myeloid leukemia

Olga K. Weinberg, Aliyah R. Sohani, Parul Bhargava, Valentina Nardi

Research output: Contribution to journalArticlepeer-review

Abstract

Acute myeloid leukemia (AML) is characterized by a clonal expansion of undifferentiated myeloid precursors resulting in impaired hematopoiesis and bone marrow failure. In 2016, the World Health Organization (WHO) published revisions to the classification of myeloid neoplasms and acute leukemias. Similar to the 2008 classification, the updated classification incorporates clinical features, morphology, immunophenotyping, and cytogenetics, with greater emphasis on molecular genetics, to define disease entities. This brief review addresses the various components of pathologic assessment to establish a diagnosis of AML and to help risk stratify patients, with an emphasis on newer techniques used in the detection of mutations with prognostic significance, as well as assays employed in the evaluation of minimal residual disease following treatment.

Original languageEnglish (US)
Pages (from-to)317-321
Number of pages5
JournalAmerican Journal of Hematology
Volume92
Issue number3
DOIs
StatePublished - Mar 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Diagnostic work-up of acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this